Apretude
Brand Name: Apretude
Generic Name: Cabotegravir
Active
Registration Number
DR-XY48834
Dosage Form
Prolonged-Release Suspension for Intramuscular Injection (Gluteal)
Issuance Date
August 3, 2023
Expiry Date
August 3, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength200 mg/mL (600 mg/3 mL)
Packaging3 mL (net content) Type I clear and colorless glass vial with bromobutyl rubber stopper and aluminum seal with orange plastic flip-off cap (box of 1 vial and 25 vials)
Classification
C
Classification
Prescription Drug (RX)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
CabotegravirActive
Monograph: Cabotegravir